openPR Logo
Press release

Biomarkers Summit

01-10-2011 12:57 PM CET | Health & Medicine

Press release from: SMi Group

SMi present their 4th annual conference on
Biomarkers Summit
Monday 31st January & Tuesday 1st February 2011
Crowne Plaza The-City, London, UK

Don’t Miss Out - Visit to register your place today
http://www.smi-online.co.uk/preclinical-biomarkers.asp

Sponsored by
Caprotec
Cell Signalling Technology
GVK Bio
Selventa
Millipore Quest Diagnostics
RBM

SMi’s highly anticipated 4th annual Biomarkers Summit is fast approaching, and time is running out to secure your place before all attendee places are gone!
The Biomarker Summit will address new developments in Biomarker Discovery, Validation, and Qualification, Stratification Biomarkers in Personalised Medicine, Pharmacology Biomarkers and PK/PD modelling and informatics to Biomarker development. Presented by 29 expert speakers over two days and two distinct presentation streams covering Oncology, Immunology & CNS.

Featuring Keynote Presentations From:
• Hans Winkler, Senior Director and Global Head, Oncology Biomarkers, Johnson & Johnson
• Mark Fidock, Associate Research Fellow, Head of Quantitative Biomarkers, Pfizer
• Huseyin Mehmet, Director of Exploratory Biomarkers, Diabetes, Merck
• Ziad Taib, Statistical Science Director, Astrazeneca

Click here to view the full list of all 29 Speakers and their presentations -
http://www.smi-online.co.uk/preclinical-biomarkers.asp

Why not attend the associated workshop as well?
"Fit for Purpose Biomarkers: From Bench to Bedside"
2nd February, 2011, Crowne Plaza The-City, London, UK
Hayley Whitaker, Research Associate, University of Cambridge / Cancer Research UK
&
Ge Ruigt, Director Experimental Medicine, Merck

You should attend this event if you are involved in;
Biomarker Discovery, Validation, and Qualification
Cancer, Immunology, or CNS Biomarker R&D
Discovery Biomarkers
Translational Science
Proteomics/Genomics/Metabolomics
Clinical Pharmacology
Experimental Medicine
Biostatistics and Bioinformatics
Early Clinical Development
Preclinical Development
Drug Metabolism
Pharmacokinetics/Pharmacodynamics (PK/PD)
Personalised Medicine
Drug and Safety Assessment


To keep up to date with this event and workshop visit:
http://www.smi-online.co.uk/preclinical-biomarkers.asp

TO BOOK
SPONSORSHIP & EXHIBITION INFORMATION
SMi Group offers excellent opportunities to profile your company through tailored sponsorship and branding packages. For details contact:
Alia Malick on tel: +44 (0) 20 7827 6168 or email: amalick@smi-online.co.uk

DELEGATE BOOKINGS
Zain Philbey on: +44 (0) 20 7827 6722 or email on: zphilbey@smi-online.co.uk
Please visit www.smi-online.co.uk/preclinical-biomarkers.asp

Supported by: b3c Newswire, Bentham Science, Biocompare, Biomarkers in Medicine, BioMEV, BioNMD, Biotechniques, Business Monitor International, Canbiotech, Drug Discovery Today, European Life Sciences, Future Drugs, Going to Meet, Health Economics, Inpharm.com, Labroots, Medchem.com, Metabolomics.net, PharmaPhorum, PharmaVoice, Pharmcast, PMR, Report Buyer, SelectsScience.net, Technology Networks, Translational Biomedicine

SMi have had an established portfolio of Pharmaceutical, Defence, Energy, Finance and PPP/PFI events running since 1993. We are at the forefront of linking businesses with information, organising over 150 Conferences, Workshops and Masterclasses every year. All our events are research driven and highly targeted towards senior level professionals, designed to help you make informed decisions and remain at the cutting edge of business information.

SMi Conferences offer you an unrivalled opportunity to network within your area of business and our Workshops and Masterclasses provide an intimate, interactive forum in which to learn about the latest techniques and developments.

SMi Group Ltd,
Unit 122, Great Guildford Business Square,
30 Great Guildford Street,
London, SE1 0HS,
United Kingdom.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biomarkers Summit here

News-ID: 157797 • Views: 910

More Releases from SMi Group

Six Key Presentations at SMi's Inaugural Robotics & Automation in Pharma Confere …
SMi Group reports: Six key presentations featured at the Robotics & Automation in Pharma Conference in London on 21-22 February 2022 SMi Group are delighted to announce the launch of the inaugural Robotics and Automation in Pharma conference, taking place on 21st and 22nd February 2022 in London, UK. The 2022 conference theme is on the latest developments in the field surrounding the integration of Robotics and Automation into the Pharmaceutical
SMi Launches it’s 6th Annual Conference and Exhibition: Future Armored Vehicle …
Armoured Vehicles Situational Awareness 2022 4th- 5th April 2022, London, United Kingdom http://www.armouredvehicles-sa.com/ Sponsors: Ni-Or Providing the Armoured Vehicle Crew with the Information to Operate in the Complex Modern Battlespace The SMi Group are pleased to present the next annual conference in the sell-out portfolio of Armoured Vehicle events: Future Armoured Vehicles Situational Awareness (FAVSA) 2022, taking place on the 4th - 5th April 2022 in London. Militaries around the world are continuing to evolve
SMi Launches its 9th Annual Pre-Filled Syringes East Coast Conference
After nearly two years of virtual meetings the industry looks set to meet face to face and have some really important discussions and you are invited to join them. SMi’s 9th Annual Conference Pre-Filled Syringes East Coast Main Conference: April 25 - 26, 2022 | Workshops: April 27, 2022 Sheraton Boston Hotel, Boston, MA, USA www.pfsamericas.com/openPR1 Sponsors are: SCHOTT, ZEON Exhibitors: Owen Mumford Pharmaceutical Services, PHC Corporation, POLYPLASTICS- TOPAS, Weiss-Aug Group Device innovations, connected delivery
Only 6 weeks to go until The Transdermal and Microneedle Delivery Conference
SMi Reports: Time is running out to Register for SM’s inaugural conference: Transdermal and Microneedle Delivery will take place on 24th - 25th January 2022 SMi Group is proud to present the inaugural Transdermal and Microneedle Drug Delivery Conference, taking place on the 24th to 25th January 2022, in London, UK. The Conference will explore real world applications of microneedles in drug delivery and strategies for device design while engaging in

All 5 Releases


More Releases for Bio

Global Bioplastics (Bio-plastics,Bio plastics) Market 2018 - Braskem, BASF
Apex Market Reports, recently published a detailed market research study focused on the “Bioplastics (Bio-plastics,Bio plastics) Market” across the global, regional and country level. The report provides 360° analysis of “Bioplastics (Bio-plastics,Bio plastics) Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Bioplastics
Bio Electronics and Bio Sensors Market Forecasts, 2017-2025
Description: The global bio electronic market is valued USD $15 billion in 2016 and is expected to grow at a CAGR of 11.6% during the forecast period 2017-2025. The market is driven by various factors such as rapid advancement in semiconductor technology, high demand in implantable medical devices, increasing prevalence of neural and cardiac diseases among others. The emerging healthcare technologies such as lab on chip, ambulatory surgical centres, and personalized devices are
Bio Simulation Technology Market
Global Bio Simulation Technology Industry Bio Simulation Technology Market is estimated at $1.01 billion in 2015 and is projected to reach $2.99 billion by 2022 growing at a CAGR of 16.6% from 2015 to 2022. Reduction in the cost of drug discovery and development and risk of failure of drug molecule are some of the factors driving the market growth. Furthermore, R&D investments in biotechnology and pharmaceutical industries, growth in the
Global Bio-Polyethylene Terephthalate (Bio-PET) Market Research Report 2021
Qyresearchreports include new market research report “Global Bio-Polyethylene Terephthalate (Bio-PET) Market Research Report 2021″ to its huge collection of research reports. This market intelligence report serves its readers with an executive-level blueprint of the global Bio-Polyethylene Terephthalate (Bio-PET) market. Data from a number of paid and unpaid sources including press releases, journals, presentations, and white papers has been taken into account for collating this report. The various factors influencing the growth of
SHANE RADBONE CORPORATE BIO
Young, dynamic and highly successful Shane founded his own business, Executive Fitness Management at age 20 in 1991. After a successful career in football that took him as high as playing for Essendon, Shane appreciated the need to have more than just sport in his portfolio. However taking his on field attitude to the corporate arena, Executive Fitness Management (EFM) grew into Australia’s largest Corporate Fitness Company. It started with
The Bio-Chromatographers’ wish
Simply high dynamic binding capacities (DBC’s) are no longer sufficient. High DBC, at high flow rates with close to 100% recovery, across a wide range of molecular weights, this is what chromatographers look for in modern ion exchange resins. “BioPro” YMC’s hugely successful ion exchange material offers exactly this. The growing user base confirms very good separation, high dynamic binding capacities and excellent recoveries for the anion as well as